Products
products details
Home > Products >
Amylin (human) Diabetes Peptides CAS 122384-88-7 Catalog no. KS032005

Amylin (human) Diabetes Peptides CAS 122384-88-7 Catalog no. KS032005

Product Details:
Catalog Number:
KS032005
Product Name:
Amylin (human)
Sequence:
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-OH (trifluoroacetate Salt) (Cys2 And 7 Bridge)
CAS NO.:
122384-88-7
Price/1mg:
$366
Purity:
≥95%
Molecular Formula:
C165H262N50O56S2
Molecular Weight:
3904.5
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

Amylin Diabetes Peptides

,

Diabetes Peptides KS032005

,

Human amylin peptide

Product Description

Amylin (human),CAS#: 122384-88-7, Catalog Number: KS032005

 

37 amino acid polypeptide secreted from the β-cells of the pancreas and structurally related to calcitonin. It has anorectic effects in rats and may be responsible for the etiology of insulin resistance of type II diabetes mellitus through its modulation of peripheral effects of insulin. It blocks the activation of glycogen synthase by insulin.

 

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australia,Asia,Middle East,Africa

 

Products
products details
Home > Products >
Amylin (human) Diabetes Peptides CAS 122384-88-7 Catalog no. KS032005

Amylin (human) Diabetes Peptides CAS 122384-88-7 Catalog no. KS032005

Product Details:
Catalog Number:
KS032005
Product Name:
Amylin (human)
Sequence:
KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-OH (trifluoroacetate Salt) (Cys2 And 7 Bridge)
CAS NO.:
122384-88-7
Price/1mg:
$366
Purity:
≥95%
Molecular Formula:
C165H262N50O56S2
Molecular Weight:
3904.5
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470411-amylin-human-diabetes-peptides-cas-122384-88-7-catalog-no-ks032005.htm
High Light: 

Amylin Diabetes Peptides

,

Diabetes Peptides KS032005

,

Human amylin peptide

Product Description

Amylin (human),CAS#: 122384-88-7, Catalog Number: KS032005

 

37 amino acid polypeptide secreted from the β-cells of the pancreas and structurally related to calcitonin. It has anorectic effects in rats and may be responsible for the etiology of insulin resistance of type II diabetes mellitus through its modulation of peripheral effects of insulin. It blocks the activation of glycogen synthase by insulin.

 

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australia,Asia,Middle East,Africa